
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Chronic liver disease is one of the most prevalent diseases in the developed world. The large amount of new knowledge has resulted in subspecialities, even in issues such as hepatology. Thus everyday, it is more difficult to access all relevant information that is being published. Additionally, biomolecular techniques lead to a level of complexity that is only beneficial when dealt with by professionals. This book attempts to give a broad overview of the molecular biology of the liver, emphasizing how this knowledge is the basis of further treatment. Thus, pathophysiology and therapies are updated in viral hepatitis, hepatic encephalopathy and portal hypertension, among others. However, appended issues that apparently are less relevant such as the stem cell and endocannabinoids are included. These two issues will soon be of importance due to their close relationship with the liver tissue and especially with liver disease. There are also new paradigms such as cell death and the implication of the extracellular matrix, which are also addressed. In addition, important issues such as the stellate cells and their intimate relationship with fibrogenesis are treated in-depth. Also the fundamental role of endothelin in chronic liver disease is examined. Because of its prevalence, NASH was discussed with special interest, with a focus on the process from fatty liver to molecular biology of liver cells and metabolism in chronic liver disease. The authors believe that this is a broad vision that describes the basic pathophysiological mechanisms shared by many liver diseases, giving rational support for specific therapies.
This book investigates the molecular underpinnings of chronic liver disease and their direct translation into therapeutic strategies.
The authors, Francisco Eizayaga and JC Perazzo, present a comprehensive overview of the molecular biology of the liver, positing that this fundamental knowledge is essential for effective treatment. The text updates current understanding of pathophysiology and therapies for conditions including viral hepatitis, hepatic encephalopathy, and portal hypertension. It also explores emerging areas such as stem cells and endocannabinoids, recognizing their growing importance in liver disease, alongside new paradigms like cell death and the extracellular matrix. In-depth discussions are dedicated to stellate cells and fibrogenesis, as well as the role of endothelin in chronic liver disease, with a particular focus on NASH from its initial stages to its molecular and metabolic complexities.
This book is positioned as a comprehensive resource for understanding the molecular basis of chronic liver disease and its therapeutic implications. It aims to consolidate recent advancements in hepatology, making complex biomolecular information accessible to professionals. The text is structured to provide a broad vision, connecting fundamental pathophysiological mechanisms to specific treatment rationales. By covering both established and emerging areas, it seeks to offer a cohesive understanding for those navigating the complexities of liver disease.
Page Count:
400
Publication Date:
2017-01-01
Publisher:
Nova Biomedical
ISBN-10:
1536102520
ISBN-13:
9781536102529
No comments yet. Be the first to share your thoughts!